Celcuity Inc

CELCNASDAQ · USD
82.71USD-0.82 (-0.99%)
1110

Celcuity Inc (CELC) Implied Volatility Current

CELC implied volatility is 62%. IV Rank is 16%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking CELC implied volatility helps you identify when options premiums on Celcuity Inc are historically cheap or expensive, and where the best trades are hiding. Celcuity Inc implied volatility reflects the market's expectation of future price movement: when CELC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Celcuity Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CELC, tracking metrics like CELC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CELC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer.

The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CELC implied volatility sits today versus where it has been. Our scanner ranks Celcuity Inc implied volatility against its historical range, surfaces extremes in CELC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Celcuity Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
15.87%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)61.55%

IV Rank15.87%

Historical Volatility (30d)50.72%

IV - HV+10.83%

As of September 14, 2026

Trade options with IV on your side

Track CELC IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial